Literature DB >> 30542430

MicroRNA-373 promotes cell migration via targeting salt-inducible kinase 1 expression in melanoma.

Xinping Bai1, Ming Yang1, Yi Xu2.   

Abstract

It is well established that altered expression of microRNAs (miRs) is critical in numerous human cancer types. Nevertheless, the molecular mechanisms of many miRs are yet to be elucidated. In the present study, reverse transcription-quantitative polymerase chain reaction and western blot analyses, and cell migration assays were performed to verify dysregulation of miR-373 in melanoma and its biological function. The transcriptional level of miR-373 was identified to be upregulated in melanoma tissues and cell lines compared with nevus and normal melanocytes. miR-373 was identified to function as an oncomiR, promoting melanoma cell migration. Notably, miR-373 was observed to suppress its downstream gene salt-inducible kinase 1 (SIK1) through directly binding the 3'-untranslated region of SIK1 expression. Furthermore, reduced SIK1 expression was identified to be responsible for the oncogenic effect of miR-373. In conclusion, the present study indicates that miR-373 functions as an oncomiR to promote melanoma progression through targeting SIK1 expression. This may provide a new therapeutic approach for melanoma.

Entities:  

Keywords:  invasion; melanoma; microRNA-373; migration; salt-inducible kinase 1

Year:  2018        PMID: 30542430      PMCID: PMC6257786          DOI: 10.3892/etm.2018.6784

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  miRNAs in melanoma: a defined role in tumor progression and metastasis.

Authors:  Francesco Mannavola; Marco Tucci; Claudia Felici; Stefania Stucci; Franco Silvestris
Journal:  Expert Rev Clin Immunol       Date:  2015-10-27       Impact factor: 4.473

3.  Defining the genetics of melanoma progression.

Authors:  Talha Khan Burki
Journal:  Lancet Oncol       Date:  2015-11-20       Impact factor: 41.316

4.  Stimulation of StAR expression by cAMP is controlled by inhibition of highly inducible SIK1 via CRTC2, a co-activator of CREB.

Authors:  Jinwoo Lee; Tiegang Tong; Hiroshi Takemori; Colin Jefcoate
Journal:  Mol Cell Endocrinol       Date:  2015-02-07       Impact factor: 4.102

5.  Metastatic melanoma of the gallbladder.

Authors:  P Cellerino; F Corsi; E Morandi; D Foschi; E Trabucchi
Journal:  Eur J Surg Oncol       Date:  2000-12       Impact factor: 4.424

6.  miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.

Authors:  Daniel W Mueller; Michael Rehli; Anja K Bosserhoff
Journal:  J Invest Dermatol       Date:  2009-02-12       Impact factor: 8.551

7.  Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.

Authors:  Chao Qu; Xiaoling Lu; Lihua Dong; Yuekun Zhu; Qin Zhao; Xin Jiang; Pengyu Chang; Xinping Jiang; Lizhe Wang; Yuyu Zhang; Lirong Bi; Jian He; Yi Peng; Jing Su; Heng Zhang; He Huang; Yan Li; Sufang Zhou; Yaqin Qu; Yongxiang Zhao; Zhiyong Zhang
Journal:  J Hepatol       Date:  2016-01-14       Impact factor: 25.083

Review 8.  Management of melanoma.

Authors:  Pippa Corrie; Mirela Hategan; Kate Fife; Christine Parkinson
Journal:  Br Med Bull       Date:  2014-09       Impact factor: 4.291

Review 9.  Diverse functions of miR-373 in cancer.

Authors:  Furong Wei; Chuanhua Cao; Xiaoqun Xu; Junfu Wang
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

10.  MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.

Authors:  D Chen; Bian-Li Dang; Jin-zhou Huang; Min Chen; Di Wu; Man-Li Xu; Rong Li; Guang-Rong Yan
Journal:  Oncotarget       Date:  2015-10-20
View more
  4 in total

Review 1.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 2.  The miRNAs Role in Melanoma and in Its Resistance to Therapy.

Authors:  Francesca Varrone; Emilia Caputo
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

3.  miR-21-5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C.

Authors:  Zhaohui Yang; Bo Liao; Xiaoyan Xiang; Sha Ke
Journal:  FEBS Open Bio       Date:  2020-03-24       Impact factor: 2.693

Review 4.  The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.

Authors:  Zicheng Sun; Qiwei Jiang; Jie Li; Jianping Guo
Journal:  Signal Transduct Target Ther       Date:  2020-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.